Summary
Suppressor cells capable of enhancing tumor growth in vivo and of abrogating a potential anti-tumor immunity in vitro are generated in C57BL/6 mice inoculated with the high-leukemogenic A-RadLV. Mice inoculated with low-leukemogenic D-RadLV do not develop suppressor cells but contain anti-tumor reactive lymphocytes that can inhibit in vivo tumor growth. Cyclophosphamide (CyF) treatment of mice inoculated with A-RadLV hampered suppressor cell function and rendered the animals' lymphocytes responsive to A-RadLV induced tumor cells in vitro. Administration of CyF also reduced leukemia incidence in mice inoculated with A-RadLV, but had no effect on leukemia induction by D-RadLV in irradiated mice. It is suggested that the high leukemogenic activity of A-RadLV depends on the virus' ability to recruit CyF-sensitive suppressor cells early in latency and that tumor progression in mice inoculated with D-RadLV is arrested due to the host immune response.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cerottini JC, Brunner KT (1974) Cell-mediated cytotoxicity, allograft rejection and tumor immunity. Adv Immunol 18:67
Chu AM, Fowler JF (1982) Effect of x-rays and cyclophosphate on solid tumors and naturally occurring metastases in mice. Cancer res 42:1943
Fujimoto S, Greene M, Sehon AH (1976) Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing mice. J Immunol 116:791
Glaser M (1979) Regulation of specific cell-mediated cytotoxic response against SV-40 induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice. J Exp Med 149:774
Haas M (1974) Continuous production of radiation leukemia virus in C57BL thymoma tissue culture lines: purification of the leukemogenic virus. Cell 1:79
Haran-Ghera N (1978) Spontaneous and induced preleukemia cells in C57BL mice. J Natl Cancer Inst 60:707
Haran-Ghera N, Peled A (1979) Induction of leukemia in mice by irradiation and by radiation leukemia virus variants. Adv Cancer Res 30:45
Haran-Ghera N, Ben Yaakov M, Peled A (1977) Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. J Immunol 118:600
Kamo I, Friedman H (1977) Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res 25:271
Kedar E, Unger E, Schwartzbach M (1979) Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes. J Immunol Methods 13:1
Kirchner H, Chused TM, Herberman RB, Holden HT, Lavrin DH (1974) Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med 139:1473
Naor D (1979) Suppressor cells: permitters and promotors of malignancy? Adv Cancer Res 29:45
North RJ (1982) Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor induced suppressor T cells. J Exp Med 155:1063
Putman DL, Kind PD, Kende M (1977) Therapy of AKR leukemia with antibody dependent normal lymphocytes and cyclophosphamide. Cancer Immunol Immunother 3:97–99
Rollinghoff M, Starzinski-Powitz A, Pfizenmaier K, Wagner H (1977) Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen specific cytotoxic T lymphocytes. J Exp Med 145:455
Ross J, Sckolnick EM, Todaro GJ, Aaronson SA (1971) Separation of murine cellular and murine leukemia virus DNA polymerases. Nature New Biol 231:163
Steele G, Pierce GE (1974) Effects of cyclophosphamide on immunity against chemically induced syngeneic murine sarcomas. Int J Cancer 13:572
Takei F, Levy JG, Kilburn D (1976) In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor bearing mice. J Immunol 116:288
Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR (1974) Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur J Immunol 4:722
Yefenof E, Zilcha D (1982) High- and low-leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor-specific immune suppression. Int J Cancer 30:355–359
Yefenof E, Meidav A, Kedar E (1980) In vitro generation of cytotoxic lymphocytes against radiation and radiation leukemia virus induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus induced leukemogenesis. J Exp Med 152:1473
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yefenof, E., Ben-David, Y. Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis. Cancer Immunol Immunother 16, 48–52 (1983). https://doi.org/10.1007/BF00199905
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199905